Cogentix Medical Company Profile (NASDAQ:CGNT)

About Cogentix Medical

Cogentix Medical logoCogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CGNT
  • CUSIP:
Key Metrics:
  • Previous Close: $2.19
  • 50 Day Moving Average: $1.98
  • 200 Day Moving Average: $1.86
  • 52-Week Range: $0.71 - $2.99
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 108.50
  • P/E Growth: -1.04
  • Market Cap: $130.96M
  • Outstanding Shares: 60,349,000
  • Beta: 0.78
  • Net Margins: -8.83%
  • Return on Equity: -17.44%
  • Return on Assets: -5.18%
  • Debt-to-Equity Ratio: 1.75%
  • Current Ratio: 1.90%
  • Quick Ratio: 1.29%
Additional Links:
Companies Related to Cogentix Medical:

Analyst Ratings

Consensus Ratings for Cogentix Medical (NASDAQ:CGNT) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $1.15 (47.00% downside)

Analysts' Ratings History for Cogentix Medical (NASDAQ:CGNT)
DateFirmActionRatingPrice TargetDetails
9/7/2016Roth CapitalUpgradeNeutral -> BuyView Rating Details
(Data available from 2/25/2015 forward)


Earnings History for Cogentix Medical (NASDAQ:CGNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/3/2016Q4($0.07)($0.04)ViewN/AView Earnings Details
11/3/2015Q216($0.07)($0.09)$11.45 million$11.80 millionViewN/AView Earnings Details
8/10/2015Q116($0.10)($0.14)$11.34 million$11.20 millionViewListenView Earnings Details
5/14/2015Q415($0.06)($0.15)$49.10 million$7.00 millionViewListenView Earnings Details
2/5/2015Q315($0.03)$4.92 million$4.51 millionViewListenView Earnings Details
8/4/2014Q115($0.04)$3.65 million$3.75 millionViewN/AView Earnings Details
2/3/2014Q3 14($0.03)$4.00 million$4.50 millionViewN/AView Earnings Details
8/12/2013Q1 2014($0.05)$34.00 million$3.70 millionViewN/AView Earnings Details
11/5/2012Q213($0.06)($0.07)$3.85 million$3.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cogentix Medical (NASDAQ:CGNT)
Current Year EPS Consensus Estimate: $-0.14 EPS
Next Year EPS Consensus Estimate: $0.02 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.05)($0.03)($0.04)
Q2 20161($0.03)($0.03)($0.03)
Q3 20161($0.04)($0.04)($0.04)
Q4 20161$0.00$0.00$0.00
Q1 20171$0.00$0.00$0.00
Q2 20171$0.00$0.00$0.00
Q3 20171$0.01$0.01$0.01
Q4 20171$0.01$0.01$0.01
(Data provided by Zacks Investment Research)


Dividend History for Cogentix Medical (NASDAQ:CGNT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Cogentix Medical (NASDAQ:CGNT)
Insider Ownership Percentage: 35.50%
Institutional Ownership Percentage: 12.74%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/18/2016Kenneth A SametDirectorBuy25,000$2.47$61,750.00View SEC Filing  
6/10/2016Lewis C PellDirectorBuy13,291$0.95$12,626.45View SEC Filing  
6/1/2016Lewis C PellDirectorBuy894$0.75$670.50View SEC Filing  
5/31/2016Lewis C PellDirectorBuy500,000$0.79$395,000.00View SEC Filing  
5/21/2015Kevin H RocheDirectorBuy10,000$1.68$16,800.00View SEC Filing  
5/19/2015Kevin H RocheDirectorBuy10,000$1.60$16,000.00View SEC Filing  
2/20/2015Lewis C PellDirectorBuy20,000$0.51$10,200.00View SEC Filing  
2/19/2015Lewis C PellDirectorBuy10,000$0.48$4,800.00View SEC Filing  
2/18/2015Lewis C PellDirectorBuy30,000$0.45$13,500.00View SEC Filing  
2/13/2015Lewis C PellDirectorBuy20,000$0.47$9,400.00View SEC Filing  
2/11/2015Lewis C PellDirectorBuy35,000$0.46$16,100.00View SEC Filing  
12/23/2014Lewis C PellDirectorBuy80,000$0.85$68,000.00View SEC Filing  
12/22/2014Lewis C PellDirectorBuy40,000$0.86$34,400.00View SEC Filing  
9/23/2014Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
9/19/2014Lewis C PellDirectorBuy3,900$1.00$3,900.00View SEC Filing  
9/17/2014Lewis C PellDirectorBuy5,000$1.02$5,100.00View SEC Filing  
9/16/2014Lewis C PellDirectorBuy5,000$1.07$5,350.00View SEC Filing  
9/12/2014Lewis C PellDirectorBuy23,300$1.04$24,232.00View SEC Filing  
9/8/2014Lewis C PellDirectorBuy30,000$1.04$31,200.00View SEC Filing  
9/3/2014Lewis C PellDirectorBuy30,000$0.98$29,400.00View SEC Filing  
8/27/2014Lewis C PellDirectorBuy10,000$0.92$9,200.00View SEC Filing  
8/26/2014Lewis C PellDirectorBuy30,000$0.93$27,900.00View SEC Filing  
8/19/2014Lewis C PellDirectorBuy22,900$0.98$22,442.00View SEC Filing  
8/13/2014Lewis C PellDirectorBuy43,420$0.91$39,512.20View SEC Filing  
8/8/2014Lewis C PellDirectorBuy27,500$0.95$26,125.00View SEC Filing  
6/6/2014Lewis C PellDirectorBuy10,000$1.13$11,300.00View SEC Filing  
5/21/2014Lewis C PellDirectorBuy5,000$1.09$5,450.00View SEC Filing  
5/16/2014Lewis C PellDirectorBuy14,197$1.02$14,480.94View SEC Filing  
11/18/2013Lewis C PellDirectorBuy6,296$0.91$5,729.36View SEC Filing  
11/15/2013Lewis C PellDirectorBuy20,000$0.90$18,000.00View SEC Filing  
9/18/2013Lewis C PellDirectorBuy16,000$0.91$14,560.00View SEC Filing  
9/13/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/10/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/9/2013Lewis C PellDirectorBuy4,564$0.95$4,335.80View SEC Filing  
9/6/2013Lewis C PellDirectorBuy5,000$0.97$4,850.00View SEC Filing  
9/3/2013Lewis C PellDirectorBuy11,432$0.97$11,089.04View SEC Filing  
8/29/2013Lewis C PellDirectorBuy1,100$0.98$1,078.00View SEC Filing  
8/27/2013Lewis C PellDirectorBuy11,596$0.97$11,248.12View SEC Filing  
8/26/2013Lewis C PellDirectorBuy14,965$0.97$14,516.05View SEC Filing  
8/19/2013Lewis C PellDirectorBuy25,025$0.94$23,523.50View SEC Filing  
8/15/2013Lewis C PellDirectorBuy15,000$0.92$13,800.00View SEC Filing  
6/28/2013Lewis C PellDirectorBuy28,400$1.00$28,400.00View SEC Filing  
6/27/2013Lewis C PellDirectorBuy45,048$0.99$44,597.52View SEC Filing  
3/15/2013Lewis C PellDirectorBuy30,000$1.14$34,200.00View SEC Filing  
3/12/2013Lewis C PellDirectorBuy45,000$1.10$49,500.00View SEC Filing  
3/7/2013Lewis C PellDirectorBuy60,000$1.09$65,400.00View SEC Filing  
3/4/2013Lewis C PellDirectorBuy20,000$1.06$21,200.00View SEC Filing  
2/26/2013Lewis C PellDirectorBuy66,266$1.01$66,928.66View SEC Filing  
2/21/2013Lewis C PellDirectorBuy25,000$0.99$24,750.00View SEC Filing  
2/19/2013Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
2/7/2013Lewis C PellDirectorBuy9,000$0.99$8,910.00View SEC Filing  
2/5/2013Lewis C PellDirectorBuy25,000$1.01$25,250.00View SEC Filing  
2/1/2013Lewis C PellDirectorBuy10,000$1.09$10,900.00View SEC Filing  
12/27/2012Lewis C PellDirectorBuy10,000$1.07$10,700.00View SEC Filing  
12/17/2012Lewis C PellDirectorBuy21,600$1.10$23,760.00View SEC Filing  
12/13/2012Lewis C PellDirectorBuy18,961$1.10$20,857.10View SEC Filing  
12/10/2012Lewis C PellDirectorBuy6,656$1.10$7,321.60View SEC Filing  
12/3/2012Lewis C PellDirectorBuy8,360$1.10$9,196.00View SEC Filing  
11/30/2012Lewis C PellDirectorBuy45,748$1.10$50,322.80View SEC Filing  
11/27/2012Lewis C PellDirectorBuy3,593$1.10$3,952.30View SEC Filing  
11/23/2012Lewis C PellDirectorBuy39,357$1.09$42,899.13View SEC Filing  
11/19/2012Lewis C PellDirectorBuy57,050$1.08$61,614.00View SEC Filing  
11/14/2012Lewis C PellDirectorBuy100,000$1.15$115,000.00View SEC Filing  
11/12/2012Lewis C PellDirectorBuy24,852$1.17$29,076.84View SEC Filing  
9/6/2012Lewis C PellDirectorBuy10,000$1.37$13,700.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Cogentix Medical (NASDAQ:CGNT)
DateHeadline logoCogentix Medical to Report Fourth Quarter Results on March 9, 2017 (NASDAQ:CGNT) - February 23 at 4:13 PM
News IconCogentix Medical Inc CGNT Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:CGNT) - February 21 at 2:52 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:CGNT) - January 6 at 4:38 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K/A, Change in Directors or Principal Officers (NASDAQ:CGNT) - January 3 at 10:59 PM logoCogentix Medical, Inc. (CGNT) - Financial and Strategic SWOT Analysis Review - New Market Report (NASDAQ:CGNT) - December 20 at 7:40 AM logoEarnings Estimates Moving Higher for Cogentix Medical (CGNT): Time to Buy? (NASDAQ:CGNT) - November 30 at 7:53 AM logoMedidata Initiates eConnect Program for Data Integration (NASDAQ:CGNT) - November 21 at 9:06 AM logoPerkinElmer: Human Health and Environmental Sales a Drag (NASDAQ:CGNT) - November 21 at 9:06 AM logoLuminex: Erasmus Assesses ARIES System, Flu A/B & RSV (NASDAQ:CGNT) - November 18 at 1:23 PM logoEdited Transcript of CGNT earnings conference call or presentation 8-Nov-16 9:30pm GMT (NASDAQ:CGNT) - November 9 at 12:29 PM logoCogentix Medical Reports 13 Percent Q3 Revenue Growth (NASDAQ:CGNT) - November 8 at 9:07 PM logoQ3 2016 Cogentix Medical Inc Earnings Release - After Market Close (NASDAQ:CGNT) - November 8 at 2:18 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material D (NASDAQ:CGNT) - November 4 at 9:28 PM logoCogentix Medical Shareholders Approve $25 Million Equity Investment (NASDAQ:CGNT) - November 3 at 8:43 PM logoETF’s with exposure to Cogentix Medical, Inc. : November 3, 2016 (NASDAQ:CGNT) - November 3 at 1:04 PM logoCogentix Medical to Report Third Quarter Results on November 8, 2016 (NASDAQ:CGNT) - October 27 at 8:42 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:CGNT) - September 26 at 4:25 PM logoCogentix Medical to Participate in the Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:CGNT) - September 20 at 10:01 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other (NASDAQ:CGNT) - September 13 at 9:00 AM logo[$$] Accelmed Making $25 Million Equity Investment in Cogentix (NASDAQ:CGNT) - September 7 at 9:15 PM logoCogentix Medical Enters Into Definitive Agreement For $25 Million Equity Investment (NASDAQ:CGNT) - September 7 at 8:56 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity (NASDAQ:CGNT) - September 7 at 8:56 AM logo"Vision-Sciences, Inc. (CGNT) - Financial and Strategic SWOT Analysis Review" now available at Fast Market Research (NASDAQ:CGNT) - August 18 at 11:41 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 10-Q, Quarterly Report (NASDAQ:CGNT) - August 15 at 11:26 AM logoEdited Transcript of CGNT earnings conference call or presentation 2-Aug-16 8:30pm GMT (NASDAQ:CGNT) - August 3 at 12:14 PM logoCogentix Medical Reports 17 Percent Q2 Revenue Growth (NASDAQ:CGNT) - August 2 at 9:47 PM logoLook at Aug 2 Medical Instrument Earnings: IDXX, DXCM, CGNT (NASDAQ:CGNT) - August 1 at 8:07 AM logoCogentix Medical to Report Second Quarter Results on August 2, 2016 (NASDAQ:CGNT) - July 20 at 7:00 AM logoCogentix names CEO after management shake-up (NASDAQ:CGNT) - July 12 at 9:39 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CGNT) - June 22 at 4:06 PM logoHealthcare Industry Leader Kenneth A. Samet Joins Cogentix Medical Board of Directors (NASDAQ:CGNT) - June 22 at 7:19 AM logoCogentix re-hires CFO who left five months ago (NASDAQ:CGNT) - June 16 at 8:34 AM logoBrett Reynolds Rejoins Cogentix Medical As Chief Financial Officer (NASDAQ:CGNT) - June 15 at 7:19 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh (NASDAQ:CGNT) - June 15 at 7:06 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S (NASDAQ:CGNT) - June 6 at 4:16 PM logoInsiders Roundup: Buy of Advance Auto Parts, Sale of Fitbit (NASDAQ:CGNT) - June 3 at 10:15 PM logoInsiders Roundup: Buys of Advance Auto Parts, Sales of Fitbit (NASDAQ:CGNT) - June 3 at 4:15 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Prin (NASDAQ:CGNT) - May 27 at 4:29 PM logoHealthcare New Lows: Five Star Quality Care (NYSE:FVE), Cogentix Medical, Inc. (NASDAQ:CGNT), Consumer ... - KC Register (NASDAQ:CGNT) - May 26 at 2:17 PM logoCogentix CEO and two board members are out after shareholder battle (NASDAQ:CGNT) - May 26 at 2:17 PM
News IconCogentix accedes to proxy war, ousts CEO Kill (NASDAQ:CGNT) - May 26 at 2:17 PM logo8:38 am Cogentix Medical announces settlement agreement in connection with proxy contest/related litigation and leadership changes; annual meeting to be held May 24 at 1pm ET (NASDAQ:CGNT) - May 24 at 8:38 AM logoCogentix Medical Announces Settlement Agreement in Connection with Proxy Contest and Related Litigation and Leadership Changes; Annual Meeting To Be Held May 24, 2016 at 12:00 P.M. Central Daylight Time (NASDAQ:CGNT) - May 24 at 8:35 AM logoCogentix Medical Adjourns May 20, 2016 Annual Meeting in Response to Court Ruling; Adjourned Meeting Date Set for May 24, 2016 at 12:00 P.M. Central Daylight Time (NASDAQ:CGNT) - May 20 at 6:23 PM logoCogentix Medical Postpones May 20, 2016 Annual Meeting in Response to Court Ruling; New Meeting Date Set for May 24, 2016 at 12:00 P.M. Central Daylight Time (NASDAQ:CGNT) - May 20 at 5:53 AM logo/C O R R E C T I O N -- Cogentix Medical, Inc./ (NASDAQ:CGNT) - May 9 at 4:28 PM logoThe Nation's Two Leading Independent Proxy Advisory Firms Recommend Support Of Cogentix Medical Board Proposals (NASDAQ:CGNT) - May 9 at 11:38 AM logoEdited Transcript of CGNT earnings conference call or presentation 5-May-16 8:30pm GMT (NASDAQ:CGNT) - May 6 at 3:57 PM logoCogentix Medical Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:CGNT) - May 5 at 4:30 PM logoCogentix Medical Achieves Second Consecutive Quarter of Cash Operating Profit; Reports 74% Revenue Growth for the Quarter Ended March 31, 2016 (NASDAQ:CGNT) - May 5 at 4:21 PM


What is Cogentix Medical's stock symbol?

Cogentix Medical trades on the NASDAQ under the ticker symbol "CGNT."

Where is Cogentix Medical's stock going? Where will Cogentix Medical's stock price be in 2017?

1 brokers have issued 1 year target prices for Cogentix Medical's stock. Their predictions range from $1.15 to $1.15. On average, they anticipate Cogentix Medical's share price to reach $1.15 in the next twelve months.

When will Cogentix Medical announce their earnings?

Cogentix Medical is scheduled to release their next quarterly earnings announcement on Wednesday, March, 1st 2017.

Who owns Cogentix Medical stock?

Cogentix Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Broadfin Capital LLC (1.25%), Renaissance Technologies LLC (0.91%), Bard Associates Inc. (0.27%) and Teton Advisors Inc. (0.19%). Company insiders that own Cogentix Medical stock include Kenneth A Samet, Kevin H Roche and Lewis C Pell.

Who sold Cogentix Medical stock? Who is selling Cogentix Medical stock?

Cogentix Medical's stock was sold by a variety of institutional investors in the last quarter, including Bard Associates Inc..

Who bought Cogentix Medical stock? Who is buying Cogentix Medical stock?

Cogentix Medical's stock was acquired by a variety of institutional investors in the last quarter, including Broadfin Capital LLC and Renaissance Technologies LLC. Company insiders that have bought Cogentix Medical stock in the last two years include Kenneth A Samet, Kevin H Roche and Lewis C Pell.

How do I buy Cogentix Medical stock?

Shares of Cogentix Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cogentix Medical stock cost?

One share of Cogentix Medical stock can currently be purchased for approximately $2.17.

Cogentix Medical (NASDAQ:CGNT) Chart for Saturday, February, 25, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Cogentix Medical (NASDAQ:CGNT)

Earnings History Chart

Earnings by Quarter for Cogentix Medical (NASDAQ:CGNT)

Dividend History Chart

Dividend Payments by Quarter for Cogentix Medical (NASDAQ:CGNT)

Last Updated on 2/25/2017 by Staff